NCT05453591View on ClinicalTrials.gov

Investigation of Urinary Biomarkers for the Detection of Breast Cancer

NAUnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

April 30, 2024

Conditions
Breast CancerUrineLiquid Biopsy
Interventions
DEVICE

Colli-Pee UAS devices

Colli-Pee UAS device variants will be evaluated during this study

Trial Locations (1)

2650

RECRUITING

Universitair ziekenhuis Antwerpen, Edegem

Sponsors

Lead Sponsor

Novosanis NV
All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

lead

Novosanis NV

INDUSTRY

NCT05453591 - Investigation of Urinary Biomarkers for the Detection of Breast Cancer | Biotech Hunter | Biotech Hunter